Noul Co., Ltd.
Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.
As of 2026-10-10, Noul Co., Ltd. has 17 Korean MFDS device approvals, 12 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- miLab™ Malaria DiagnosticsMalaria diagnosis
- miLab™ Peripheral Blood Smear TestPeripheral blood smear testing
- miLab™ Cervical Cytology AnalysisCervical cytology analysis (cancer diagnosis)
Regulatory approvals
data.go.kr17 Korean MFDS device approvals · 2019–2024
- MFDSHematology analyzer, cell-quantifying2024-10-25Product approval · Class 1체외 제신 24-1310 호
- MFDSImage processing software for pathological cells or tissue2023-12-04Product approval · Class 1체외 제신 23-1722 호
- MFDSComputer aided diagnosis software for pathological cells or tissue2023-09-22Product approval · Class 3체외 제허 23-940 호
- MFDSComputer aided diagnosis software for pathological cells or tissue2023-09-01Product approval · Class 3체외 제허 23-887 호
- MFDSCell/histopathologic image processor2023-08-01Product approval · Class 1체외 제신 23-1182 호
- MFDSHistological staining reagent Ⅰ2022-11-09Product approval · Class 1체외 제신 22-1564 호
- MFDSHistological staining reagent Ⅰ2022-11-09Product approval · Class 1체외 제신 22-1563 호
- MFDSHistological staining reagent Ⅰ2022-02-08Product approval · Class 1체외 제신 22-162 호
- MFDSIVD reagents for hematological stains2021-04-26Product approval · Class 1체외 제신 21-564 호
- MFDSHistological staining reagent ⅠRevoked2021-04-09Product approval · Class 1체외 제신 21-484 호
- MFDSIVD reagents for hematological stains2021-04-09Product approval · Class 1체외 제신 21-483 호
- MFDSHistological staining reagent ⅠRevoked2021-04-08Product approval · Class 1체외 제신 21-480 호
Show 5 more
- MFDSHistological staining reagent ⅠRevoked2021-04-08Product approval · Class 1체외 제신 21-479 호
- MFDSHistological staining reagent ⅠRevoked2021-02-01Product approval · Class 1체외 제신 21-127 호
- MFDSCell/histopathology diagnostic analyzerRevoked2020-09-02Product approval · Class 2체외 제허 20-774 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2020-03-16Product approval · Class 3체외 제허 20-188 호
- MFDSHematology analyzer, cell-quantifying2019-10-08Product approval · Class 1체외 제신 19-1320 호
Key disclosures
KRX KIND via OpenDARTShow 12 more events
- Management투자판단관련주요경영사항 (Nihon Koden Mexico와 마이랩(miLab)플랫폼 등 총 4종 제품 멕시코 공급 및 판매권 부여 계약 체결)2025-06-09
Publications
PubMed · affiliation-matched- Diagnosis of Plasmodium infections using artificial intelligence techniques versus standard microscopy in a reference laboratory.
Journal of clinical microbiology · 2025-01 · Nagendra S, Hayes R, Bae D 외 1
- A large multi-focus dataset for white blood cell classification.
Scientific data · 2024-10 · Park S, Cho H, Woo BM 외 7
- Plasmodium falciparum transmission in the highlands of Ethiopia is driven by closely related and clonal parasites.
Molecular ecology · 2024-03 · Holzschuh A, Ewnetu Y, Carlier L 외 8
- Enhancing malaria detection in resource-limited areas: A high-performance colorimetric LAMP assay for Plasmodium falciparum screening.
PloS one · 2024-01 · Nguyen TK, Jun H, Louis JM 외 16
- Embedded-deep-learning-based sample-to-answer device for on-site malaria diagnosis.
Frontiers in bioengineering and biotechnology · 2024-01 · Bae CY, Shin YM, Kim M 외 14
- Quantification of solution-free red blood cell staining by sorption kinetics of Romanowsky stains to agarose gels.
Analytical methods : advancing methods and applications · 2023-10 · Bae CY, Esmaeili H, Zamin SA 외 6
- Solution-free and simplified H&E staining using a hydrogel-based stamping technology.
Frontiers in bioengineering and biotechnology · 2023-01 · Kim J, Choi W, Yoo D 외 8
- Hydrogel Stamping for Rapid, Multiplexed, Point-of-Care Immunostaining of Cells and Tissues.
ACS applied materials & interfaces · 2022-06 · Chin LK, Li H, Choi JH 외 8
- Knowledge, Attitudes and Perceptions Regarding Endemic Vivax Malaria in Inhabitants and Patients in Two Cities of Northern Gyeonggi-do, Korea, 2020.
The Korean journal of parasitology · 2021-12 · Bahk YY, Cho SH, Park S 외 7
- Awareness and Opinions of Inhabitants on Vivax Malaria in Two Endemic Areas, Gyeonggi-do, Korea.
The Korean journal of parasitology · 2021-10 · Bahk YY, Cho SH, Na BK 외 3
Show 2 more publications
- An Epidemiological Analysis of 28 Vivax Malaria Cases in Gimpo-si, Korea, 2020.
The Korean journal of parasitology · 2021-10 · Bahk YY, Cho SH, Kim KN 외 8
- Hydrogel-Based Stamping Technology for Solution-Free Blood Cell Staining.
ACS applied materials & interfaces · 2021-05 · Choi JH, Chin LK, Woo BM 외 8
Patents
KIPRIS · applicant-matchedUS · Published · 2026-02 · Application 19535333
US · Published · 2025-10 · Application 19376576
US · Published · 2024-12 · Application 19000072
US · Published · 2024-11 · Application 18945241
PCT · Published · 2024-11 · Application PCT/KR2024/017417
PCT · Published · 2024-11 · Application PCT/KR2024/017416
PCT · Published · 2024-08 · Application PCT/KR2024/096039
CN · Published · 2024-02 · Application 202480011484.1
US · Published · 2024-01 · Application 18855706
EP · Published · 2024-01 · Application 24744831.9
Show 117 more patents
PCT · Published · 2024-01 · Application PCT/KR2024/000716
US · Registered · 2024-01 · Application 18403459
US · Registered · 2023-08 · Application 18364392
US · Registered · 2023-07 · Application 18351796
Registered · 2023-05 · Application 1020230062525
PCT · Published · 2023-03 · Application PCT/KR2023/003168
PCT · Published · 2023-03 · Application PCT/KR2023/003171
Registered · 2023-03 · Application 1020230030195
Published · 2023-02 · Application 1020230016900
US · Registered · 2023-01 · Application 18160985
Registered · 2022-12 · Application 1020220173046
Registered · 2022-09 · Application 1020220124650
Registered · 2022-09 · Application 1020220124649
US · Published · 2022-06 · Application 17842651
US · Published · 2022-04 · Application 18548360
PCT · Published · 2022-04 · Application PCT/IB2022/053088
Rejected · 2022-04 · Application 1020237027009
Registered · 2022-03 · Application 1020220029461
US · Registered · 2021-10 · Application 17512571
Registered · 2021-05 · Application 1020210065715
US · Published · 2021-05 · Application 17322803
Registered · 2021-01 · Application 1020210011788
PCT · Published · 2020-09 · Application PCT/KR2020/013368
Withdrawn · 2020-09 · Application 1020227011828
Registered · 2020-03 · Application 1020200037756
Registered · 2020-03 · Application 1020200036988
US · Published · 2019-11 · Application 17294596
PCT · Published · 2019-11 · Application PCT/KR2019/015830
Registered · 2019-11 · Application 1020190143009
Registered · 2019-11 · Application 1020190143008
Registered · 2019-11 · Application 1020190143007
Registered · 2019-11 · Application 1020190142554
Registered · 2019-11 · Application 1020190142553
US · Registered · 2019-09 · Application 16585665
US · Registered · 2019-09 · Application 16585600
US · Published · 2019-06 · Application 16455484
US · Registered · 2019-05 · Application 16417419
US · Published · 2019-04 · Application 17052403
PCT · Published · 2019-04 · Application PCT/KR2019/005215
PCT · Published · 2019-04 · Application PCT/KR2019/003930
Registered · 2018-11 · Application 1020180142831
Registered · 2018-11 · Application 1020180136665
Withdrawn · 2018-10 · Application 1020180124097
Withdrawn · 2018-10 · Application 1020180124096
Withdrawn · 2018-05 · Application 1020180051323
Registered · 2018-05 · Application 1020180051325
Withdrawn · 2018-05 · Application 1020180051324
Registered · 2018-05 · Application 1020180051322
CN · Published · 2017-12 · Application 201780090223.3
US · Published · 2017-12 · Application 16610045
EP · Published · 2017-12 · Application 17922095.9
PCT · Published · 2017-12 · Application PCT/KR2017/014157
Withdrawn · 2017-08 · Application 1020170106791
Registered · 2017-08 · Application 1020170106500
US · Published · 2017-07 · Application 16631382
PCT · Published · 2017-07 · Application PCT/KR2017/007671
Registered · 2017-07 · Application 1020170090596
Registered · 2017-07 · Application 1020170087861
Rejected · 2017-07 · Application 1020170087857
Registered · 2017-07 · Application 1020170087859
Registered · 2017-07 · Application 1020170087856
Registered · 2017-07 · Application 1020170087860
Rejected · 2017-07 · Application 1020170087858
US · Registered · 2017-04 · Application 15498343
CN · Published · 2017-02 · Application 201780025367.0
CN · Published · 2017-02 · Application 202110067930.9
CN · Published · 2017-02 · Application 201780025355.8
CN · Published · 2017-02 · Application 201780025321.9
CN · Published · 2017-02 · Application 201780025053.0
CN · Published · 2017-02 · Application 201780025111.X
CN · Published · 2017-02 · Application 201780025078.0
CN · Published · 2017-02 · Application 201780025297.9
EP · Registered · 2017-02 · Application 24180166.1
US · Registered · 2017-02 · Application 16079485
US · Registered · 2017-02 · Application 16079451
US · Registered · 2017-02 · Application 16079299
US · Published · 2017-02 · Application 16079236
US · Published · 2017-02 · Application 16079406
US · Registered · 2017-02 · Application 16079360
US · Published · 2017-02 · Application 16079271
EP · Registered · 2017-02 · Application 21207600.4
EP · Registered · 2017-02 · Application 17756846.6
EP · Published · 2017-02 · Application 26150992.1
EP · Published · 2017-02 · Application 23206371.9
EP · Published · 2017-02 · Application 23206369.3
EP · Published · 2017-02 · Application 23172630.8
EP · Published · 2017-02 · Application 23172629.0
EP · Registered · 2017-02 · Application 17756843.3
EP · Registered · 2017-02 · Application 17756844.1
EP · Registered · 2017-02 · Application 17756842.5
EP · Published · 2017-02 · Application 17756841.7
EP · Registered · 2017-02 · Application 17756845.8
EP · Published · 2017-02 · Application 17756840.9
PCT · Published · 2017-02 · Application PCT/KR2017/002032
PCT · Published · 2017-02 · Application PCT/KR2017/002030
PCT · Published · 2017-02 · Application PCT/KR2017/002031
PCT · Published · 2017-02 · Application PCT/KR2017/002027
PCT · Published · 2017-02 · Application PCT/KR2017/002028
PCT · Published · 2017-02 · Application PCT/KR2017/002029
PCT · Published · 2017-02 · Application PCT/KR2017/002026
JP · Registered · 2017-02 · Application 30562492
JP · Registered · 2017-02 · Application 30562490
JP · Registered · 2017-02 · Application 30562491
JP · Registered · 2017-02 · Application 30562489
Registered · 2017-02 · Application 1020170024388
Registered · 2017-02 · Application 1020170024389
Registered · 2017-02 · Application 1020170024392
Registered · 2017-02 · Application 1020170024387
Registered · 2017-02 · Application 1020170024391
Rejected · 2017-02 · Application 1020170024390
Withdrawn · 2016-11 · Application 1020160144551
Withdrawn · 2016-09 · Application 1020160118462
Withdrawn · 2016-07 · Application 1020160095739
US · Registered · 2016-07 · Application 15206247
Withdrawn · 2016-06 · Application 1020160069938
Withdrawn · 2016-06 · Application 1020160069936
Withdrawn · 2016-06 · Application 1020160069937
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive1
- OpenAIOAI-SearchBot52
- GoogleGoogleOther18
- AnthropicClaudeBot2
- PerplexityPerplexityBot2
Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Noul Co., Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
Vieworks, founded in 1999 and KOSDAQ-listed in 2009, develops X-ray detectors and industrial camera imaging solutions.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
KOSDAQ-listed bioprocess and biomedical company supplying the CELBIC single-use cell culture system and the DxBIC automated analysis system.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
IVIM Technology provides all-in-one intravital microscopes and CRO imaging-analysis services for live-animal organ and tissue research.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition